Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Follow-Up Study for Exubera

ClinicalTrials.gov ID: NCT00734591

Public ClinicalTrials.gov record NCT00734591. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 3:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

In studies of Exubera in persons with diabetes, lung cancer occurred in a few more people who were taking Exubera than in people who were taking other diabetes medicines. All subjects diagnosed with lung cancer had a history of smoking and the number of lung cancer cases observed fell within the expected range based on population-based data. There is currently not enough information to determine if any of the observed lung cancer cases were related to Exubera use, therefore, the study is being conducted to further investigate whether Exubera use makes the appearance of lung cancer more likely.

Study identification

NCT ID
NCT00734591
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Pfizer
Industry
Enrollment
7,439 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2008
Primary completion
Dec 31, 2011
Completion
Dec 31, 2011
Last update posted
Oct 22, 2012

2008 – 2012

United States locations

U.S. sites
131
U.S. states
36
U.S. cities
114
Facility City State ZIP Site status
Pfizer Investigational Site Bay Minette Alabama 36507
Pfizer Investigational Site Graysville Alabama 35073
Pfizer Investigational Site Pell City Alabama 35125
Pfizer Investigational Site Pell City Alabama 35128
Pfizer Investigational Site Glendale Arizona 85306
Pfizer Investigational Site Phoenix Arizona 85006
Pfizer Investigational Site Phoenix Arizona 85016
Pfizer Investigational Site Phoenix Arizona 85028
Pfizer Investigational Site Phoenix Arizona 85051
Pfizer Investigational Site Forrest City Arkansas 72335
Pfizer Investigational Site Berkeley California 94705
Pfizer Investigational Site Concord California 94520
Pfizer Investigational Site El Cajon California 92019
Pfizer Investigational Site Encino California 91436
Pfizer Investigational Site Fresno California 93720
Pfizer Investigational Site Fullerton California 92835
Pfizer Investigational Site Huntington Beach California 92648
Pfizer Investigational Site Long Beach California 90806
Pfizer Investigational Site Los Angeles California 90073
Pfizer Investigational Site Rolling Hills Estates California 90274
Pfizer Investigational Site San Diego California 92120
Pfizer Investigational Site San Diego California 92128
Pfizer Investigational Site San Jose California 95116
Pfizer Investigational Site Santa Ana California 92704
Pfizer Investigational Site Santa Barbara California 93105
Pfizer Investigational Site Tustin California 92780
Pfizer Investigational Site Denver Colorado 80206
Pfizer Investigational Site Denver Colorado 80209
Pfizer Investigational Site Denver Colorado 80220
Pfizer Investigational Site Golden Colorado 80401
Pfizer Investigational Site Longmont Colorado 80501
Pfizer Investigational Site Milford Connecticut 06460
Pfizer Investigational Site Newark Delaware 19713
Pfizer Investigational Site Washington D.C. District of Columbia 20010
Pfizer Investigational Site Washington D.C. District of Columbia 20307
Pfizer Investigational Site Boca Raton Florida 33433
Pfizer Investigational Site Chiefland Florida 32626
Pfizer Investigational Site Green Cove Springs Florida 32043
Pfizer Investigational Site Kissimmee Florida 34743
Pfizer Investigational Site Lake City Florida 32025
Pfizer Investigational Site Lake Mary Florida 32746
Pfizer Investigational Site Miami Florida 33136
Pfizer Investigational Site Opa-locka Florida 33054-3818
Pfizer Investigational Site Saint Cloud Florida 34769
Pfizer Investigational Site Tampa Florida 33624
Pfizer Investigational Site West Palm Beach Florida 33401
Pfizer Investigational Site Atlanta Georgia 30318-2513
Pfizer Investigational Site Atlanta Georgia 30342
Pfizer Investigational Site Conyers Georgia 30013
Pfizer Investigational Site Decatur Georgia 30035
Pfizer Investigational Site Honolulu Hawaii 96813
Pfizer Investigational Site Honolulu Hawaii 96814
Pfizer Investigational Site Hayden Lake Idaho 83835
Pfizer Investigational Site Greenville Illinois 62246
Pfizer Investigational Site Normal Illinois 61761
Pfizer Investigational Site Olympia Fields Illinois 60461
Pfizer Investigational Site Springfield Illinois 62704
Pfizer Investigational Site Fishers Indiana 46038
Pfizer Investigational Site Indianapolis Indiana 46229
Pfizer Investigational Site Indianapolis Indiana 46254-5472
Pfizer Investigational Site Des Moines Iowa 50314
Pfizer Investigational Site Des Moines Iowa 50315
Pfizer Investigational Site Dubuque Iowa 52002
Pfizer Investigational Site Wichita Kansas 67203
Pfizer Investigational Site Louisville Kentucky 40213
Pfizer Investigational Site Louisville Kentucky 40258
Pfizer Investigational Site Mount Sterling Kentucky 40353
Pfizer Investigational Site Baltimore Maryland 21204
Pfizer Investigational Site Elkton Maryland 21921
Pfizer Investigational Site Glen Burnie Maryland 21061
Pfizer Investigational Site Wheaton Maryland 20902
Pfizer Investigational Site Boston Massachusetts 02114
Pfizer Investigational Site Springfield Massachusetts 01105
Pfizer Investigational Site Ann Arbor Michigan 48104
Pfizer Investigational Site Clinton Michigan 49236
Pfizer Investigational Site Flint Michigan 48532
Pfizer Investigational Site Muskegon Michigan 49444
Pfizer Investigational Site Saint Cloud Minnesota 56301
Pfizer Investigational Site Kansas City Missouri 64116
Pfizer Investigational Site Springfield Missouri 65807
Pfizer Investigational Site Incline Village Nevada 89452
Pfizer Investigational Site Las Vegas Nevada 89128
Pfizer Investigational Site Belvidere New Jersey 07823
Pfizer Investigational Site New Brunswick New Jersey 08901
Pfizer Investigational Site Albuquerque New Mexico 87106
Pfizer Investigational Site Albany New York 12208
Pfizer Investigational Site Babylon New York 11702
Pfizer Investigational Site Brooklyn New York 11224
Pfizer Investigational Site Minneola New York 11501
Pfizer Investigational Site New Hartford New York 13413
Pfizer Investigational Site Syracuse New York 13210
Pfizer Investigational Site Williamsville New York 14221
Pfizer Investigational Site Asheboro North Carolina 27203
Pfizer Investigational Site Charlotte North Carolina 28227
Pfizer Investigational Site Durham North Carolina 27713
Pfizer Investigational Site Morehead City North Carolina 28557-3126
Pfizer Investigational Site Raleigh North Carolina 27609
Pfizer Investigational Site Tabor City North Carolina 28463
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Columbus Ohio 43207
Pfizer Investigational Site Dayton Ohio 45419
Pfizer Investigational Site Kettering Ohio 45429
Pfizer Investigational Site Marietta Ohio 45750
Pfizer Investigational Site Portland Oregon 97210
Pfizer Investigational Site Portland Oregon 97232
Pfizer Investigational Site Fogelsville Pennsylvania 18051
Pfizer Investigational Site Hanover Pennsylvania 17331
Pfizer Investigational Site Harrisburg Pennsylvania 17112
Pfizer Investigational Site Jeannette Pennsylvania 15644
Pfizer Investigational Site Jersey Shore Pennsylvania 17740
Pfizer Investigational Site Lansdale Pennsylvania 19446
Pfizer Investigational Site Melrose Park Pennsylvania 19027
Pfizer Investigational Site Philadelphia Pennsylvania 19153-2326
Pfizer Investigational Site Charleston South Carolina 29412
Pfizer Investigational Site North Myrtle Beach South Carolina 29582
Pfizer Investigational Site Beaumont Texas 77701
Pfizer Investigational Site Dallas Texas 75246
Pfizer Investigational Site Houston Texas 77008
Pfizer Investigational Site Houston Texas 77079
Pfizer Investigational Site Kaufman Texas 75142
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site San Marcos Texas 78666
Pfizer Investigational Site Stephenville Texas 76401
Pfizer Investigational Site Webster Texas 77598
Pfizer Investigational Site South Burlington Vermont 05403
Pfizer Investigational Site Richmond Virginia 23225-4017
Pfizer Investigational Site Richmond Virginia 23294
Pfizer Investigational Site Federal Way Washington 98003
Pfizer Investigational Site Spokane Washington 99204
Pfizer Investigational Site Spokane Washington 99207
Pfizer Investigational Site Burnsville West Virginia 26335

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 190 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00734591, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2012 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00734591 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →